Advertisement

Payer

Advertisement

Humana is right behind the federal government in suing Regeneron for allegedly inflating its macular degeneration drug, Eylea, and using a "sham" charity to pay out kickbacks to cover cost-sharing obligations, according to the lawsuit. 

Humana released its second-quarter earnings results July 28 on the tails of payers still reporting a dropoff in profits. 

Advertisement